AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27356102 — intervention group
Group type: COMPARATOR
Intervention: Low-protein diet (5%)
Number of subjects: 24
Study 26633481 — intervention group
Group type: EXPERIMENTAL
Intervention: CDRI 08 (special extract of Bacopa monnieri)
Number of subjects: 0
Study 26633481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24204790 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% hypohydration (3H)
Number of subjects: 32
Study 24204790 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% hypohydration (4H)
Number of subjects: 32
Study 24204790 — intervention group
Group type: COMPARATOR
Intervention: Euhydrated (EU)
Number of subjects: 32
Study 21504616 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole in situ gels (0.5% w/v) for 14 days
Number of subjects: 45
Study 21504616 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole tablets (100 mg/day) for 14 days
Number of subjects: 45
Study 18291275 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraosseous injection using the IntraFlow system
Number of subjects: 30
Study 18291275 — intervention group
Group type: COMPARATOR
Intervention: IA nerve block
Number of subjects: 30
Study 16908767 — intervention group
Group type: EXPERIMENTAL
Intervention: Skeletonized ITA
Number of subjects: 48
Study 16908767 — intervention group
Group type: COMPARATOR
Intervention: Nonskeletonized ITA
Number of subjects: 48
Study 12697850 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision Board plus medical consultation
Number of subjects: 176
Study 12697850 — intervention group
Group type: COMPARATOR
Intervention: Medical consultation alone
Number of subjects: 176
Study 10634373 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (600 mg/day)
Number of subjects: 40
Study 10634373 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 9021813 — intervention group
Group type: EXPERIMENTAL
Intervention: Propacetamol (30 mg/kg)
Number of subjects: 34
Study 9021813 — intervention group
Group type: COMPARATOR
Intervention: Propacetamol (15 mg/kg)
Number of subjects: 34
Study 8199795 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline prescribed by a psychiatrist
Number of subjects: 121
Study 8199795 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy from a clinical psychologist
Number of subjects: 121
Study 8199795 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling and case work by a social worker
Number of subjects: 121
Study 8199795 — intervention group
Group type: COMPARATOR
Intervention: Routine care by a general practitioner
Number of subjects: 121
Study 3071176 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (Temgesic)
Number of subjects: 76
Study 3071176 — intervention group
Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 76
Study 3071176 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 76
Study 29379114 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation (CR) plus a weekly goal-setting group
Number of subjects: 77
Study 29379114 — intervention group
Group type: COMPARATOR
Intervention: Portable cognitive-games (CG)
Number of subjects: 77
Study 29379114 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation (CR)
Number of subjects: 77
Study 29379114 — intervention group
Group type: EXPERIMENTAL
Intervention: Both VR + CG and VR + CR
Number of subjects: 77
Study 27115772 — intervention group
Group type: EXPERIMENTAL
Intervention: Thai Traditional Herbal Formula (TTHF)
Number of subjects: 15
Study 27115772 — intervention group
Group type: COMPARATOR
Intervention: Mebendazole
Number of subjects: 15
Study 24395315 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy (group 1)
Number of subjects: 180
Study 24395315 — intervention group
Group type: EXPERIMENTAL
Intervention: Acromioplasty and physiotherapy (group 2)
Number of subjects: 180
Study 24395315 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotator cuff repair, acromioplasty and physiotherapy (group 3)
Number of subjects: 180
Study 22939029 — intervention group
Group type: EXPERIMENTAL
Intervention: Compensatory cognitive training + standard pharmacotherapy
Number of subjects: 69
Study 22939029 — intervention group
Group type: COMPARATOR
Intervention: Standard pharmacotherapy alone
Number of subjects: 69
Study 19165785 — intervention group
Group type: EXPERIMENTAL
Intervention: HA/Coll/mTGase 0/100
Number of subjects: 2
Study 19165785 — intervention group
Group type: EXPERIMENTAL
Intervention: HA/Coll/mTGase 80/20
Number of subjects: 2
Study 19165785 — intervention group
Group type: EXPERIMENTAL
Intervention: mTGase-crosslinked samples
Number of subjects: 2
Study 19165785 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaffolds with mTGase treatment
Number of subjects: 2
Study 18434733 — intervention group
Group type: EXPERIMENTAL
Intervention: Abciximab
Number of subjects: 2159
Study 18434733 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2159
Study 15955154 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate or budesonide, initial dose of 300, 400 or 600 microg/day, reduced to maintenance level of 200, 300 or 400 microg/day after stabilization.
Number of subjects: 86
Study 11992983 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical training for eight weeks at 50% of baseline VO2max
Number of subjects: 24
Study 11992983 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation therapy for eight weeks
Number of subjects: 24
Study 11992983 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 24
Study 8109759 — intervention group
Group type: EXPERIMENTAL
Intervention: mivacurium 0.2 mg/kg, IV (Group II)
Number of subjects: 60
Study 8109759 — intervention group
Group type: COMPARATOR
Intervention: succinylcholine 1 mg/kg, IV (Group I)
Number of subjects: 60
Study 8109759 — intervention group
Group type: EXPERIMENTAL
Intervention: mivacurium 0.2 mg/kg, IV (Group III)
Number of subjects: 60
Study 8109759 — intervention group
Group type: EXPERIMENTAL
Intervention: neostigmine 2.5 mg and glycopyrrolate 0.5 mg, IV (Group III)
Number of subjects: 60
Study 8109759 — intervention group
Group type: EXPERIMENTAL
Intervention: mivacurium (all groups)
Number of subjects: 60
Study 8109759 — intervention group
Group type: COMPARATOR
Intervention: succinylcholine (Group I)
Number of subjects: 60
Study 2660974 — intervention group
Group type: EXPERIMENTAL
Intervention: Transrectal needle aspiration biopsy
Number of subjects: 88
Study 2660974 — intervention group
Group type: COMPARATOR
Intervention: Core biopsy
Number of subjects: 88
Study 30955365 — intervention group
Group type: EXPERIMENTAL
Intervention: High dietary intake of folate
Number of subjects: 3185
Study 30955365 — intervention group
Group type: EXPERIMENTAL
Intervention: High dietary intake of vitamin B6
Number of subjects: 3185
Study 30955365 — intervention group
Group type: COMPARATOR
Intervention: B vitamins (thiamin, niacin, riboflavin)
Number of subjects: 3185
Study 27513733 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric leg extension holds at 60 degrees knee flexion (80% of their maximal voluntary isometric contraction)
Number of subjects: 20
Study 27513733 — intervention group
Group type: COMPARATOR
Intervention: Isotonic leg extension (at 80% of their 8 repetition maximum)
Number of subjects: 20
Study 25145943 — intervention group
Group type: EXPERIMENTAL
Intervention: Veterans
Number of subjects: 6577
Study 25145943 — intervention group
Group type: COMPARATOR
Intervention: Non-veterans
Number of subjects: 6577
Study 25145943 — intervention group
Group type: EXPERIMENTAL
Intervention: Vietnam War veterans
Number of subjects: 6577
Study 23550856 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 40 mg, repeated after 4 h as needed
Number of subjects: 130
Study 23550856 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol 25 μg, repeated after 4 h as needed
Number of subjects: 130
Study 23550856 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN)
Number of subjects: 130
Study 21334136 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA <3.0 ng/ml screening
Number of subjects: 15758
Study 21334136 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval cancers detected
Number of subjects: 15758
Study 21334136 — intervention group
Group type: EXPERIMENTAL
Intervention: Screen-detected cancers
Number of subjects: 15758
Study 21334136 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall PCa mortality
Number of subjects: 15758
Study 20048486 — intervention group
Group type: EXPERIMENTAL
Intervention: Lean fish diet
Number of subjects: 0
Study 20048486 — intervention group
Group type: COMPARATOR
Intervention: Beef diet
Number of subjects: 0
Study 20048486 — intervention group
Group type: COMPARATOR
Intervention: Cholesterol-free diet
Number of subjects: 0
Study 17313607 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphologists
Number of subjects: 80
Study 17313607 — intervention group
Group type: EXPERIMENTAL
Intervention: Internists
Number of subjects: 80
Study 17313607 — intervention group
Group type: COMPARATOR
Intervention: Both evaluators (Graphologists and Internists)
Number of subjects: 80
Study 15562900 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin (10 days)
Number of subjects: 60
Study 15562900 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefprozil (10 days)
Number of subjects: 60
Study 15562900 — intervention group
Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 60
Study 11560366 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% body mass load in a bookbag
Number of subjects: 30
Study 11560366 — intervention group
Group type: COMPARATOR
Intervention: Empty pack (no load)
Number of subjects: 30
Study 9778071 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril 5 to 20 mg every day
Number of subjects: 254
Study 9778071 — intervention group
Group type: COMPARATOR
Intervention: Enalapril 5 to 20 mg every day
Number of subjects: 254
Study 7609497 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacidipine 4 mg once daily for 1 week
Number of subjects: 40
Study 7609497 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 20 mg twice daily for 1 week
Number of subjects: 40
Study 7609497 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 1 week
Number of subjects: 40
Study 2672434 — intervention group
Group type: EXPERIMENTAL
Intervention: True plasma exchange
Number of subjects: 294
Study 2672434 — intervention group
Group type: COMPARATOR
Intervention: Sham plasma exchange
Number of subjects: 294
Study 1083792 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular-proprioceptive stimulation (horizontal or semivertical position)
Number of subjects: 48
Study 1083792 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacifier sucking
Number of subjects: 48
Study 1083792 — intervention group
Group type: COMPARATOR
Intervention: Upright position
Number of subjects: 48
Study 31308627 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (150 mg) and celecoxib (200 mg) 2 hrs before surgery
Number of subjects: 60
Study 31308627 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 29113045 — intervention group
Group type: EXPERIMENTAL
Intervention: Sourdough wheat bread
Number of subjects: 26
Study 29113045 — intervention group
Group type: COMPARATOR
Intervention: Yeast-fermented wheat bread
Number of subjects: 26
Study 25467705 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT)
Number of subjects: 30
Study 25467705 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 22947271 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiation for patients with mesorectal nodes >7 mm
Number of subjects: 0
Study 22947271 — intervention group
Group type: EXPERIMENTAL
Intervention: Treat all patients with preoperative chemoradiation
Number of subjects: 0
Study 22947271 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiation for patients with mesorectal nodes >3 mm
Number of subjects: 0
Study 22947271 — intervention group
Group type: EXPERIMENTAL
Intervention: No preoperative treatment
Number of subjects: 0
Study 22134883 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to music during warm-up
Number of subjects: 12
Study 22134883 — intervention group
Group type: COMPARATOR
Intervention: No music during warm-up
Number of subjects: 12
Study 19156705 — intervention group
Group type: EXPERIMENTAL
Intervention: LM + Met
Number of subjects: 0
Study 19156705 — intervention group
Group type: COMPARATOR
Intervention: G + Met
Number of subjects: 0
Study 19156705 — intervention group
Group type: EXPERIMENTAL
Intervention: Confirmed hypoglycaemia
Number of subjects: 0
Study 19156705 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA(1c)
Number of subjects: 0
Study 17178796 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir (ETV) 1.0 mg
Number of subjects: 192
Study 15083366 — intervention group
Group type: EXPERIMENTAL
Intervention: Air Ventilation (AV) at 3 m s(‐1)
Number of subjects: 14
Study 15083366 — intervention group
Group type: COMPARATOR
Intervention: No Air Ventilation (NAV)
Number of subjects: 14
Study 15083366 — intervention group
Group type: EXPERIMENTAL
Intervention: Air Ventilation (AV)
Number of subjects: 14
Study 11786772 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine (40 ml of 0.75 percent)
Number of subjects: 34
Study 11786772 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline infiltration
Number of subjects: 34
Study 9844260 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive computer classroom (ICC)
Number of subjects: 0
Study 9844260 — intervention group
Group type: COMPARATOR
Intervention: Traditional lecture/discussion format (LD)
Number of subjects: 0
Study 7986518 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual clonidine 0.3 mg
Number of subjects: 10
Study 7986518 — intervention group
Group type: COMPARATOR
Intervention: Oral clonidine 0.3 mg
Number of subjects: 10
Study 2493098 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg mitomycin C with 200,000 units hyaluronidase
Number of subjects: 28
Study 2493098 — intervention group
Group type: COMPARATOR
Intervention: 20 mg mitomycin C alone
Number of subjects: 28
Study 241454 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenelzine
Number of subjects: 28
Study 241454 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 31617059 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ‐5D‐5L index values
Number of subjects: 1215
Study 31617059 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex, age, cohabitation, social support
Number of subjects: 1215
Study 31617059 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression/anxiety
Number of subjects: 1215
Study 30300020 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense pulsed light (IPL) therapy, 4 sessions of 29J/cm2 at 3 weekly intervals
Number of subjects: 28
Study 30300020 — intervention group
Group type: COMPARATOR
Intervention: Silicone gel sheet (SGS), applied over the other half of the scar and changed at 3 weekly intervals
Number of subjects: 28
Study 29364096 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin containing sequential therapy with bismuth
Number of subjects: 190
Study 29364096 — intervention group
Group type: COMPARATOR
Intervention: Levofloxacin containing sequential therapy
Number of subjects: 190
Study 29364096 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 190
Study 25626448 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 720
Study 25626448 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate-amodiaquine (ASAQ)
Number of subjects: 720
Study 25626448 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin piperaquine (DHAP)
Number of subjects: 720
Study 25626448 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL) vs Artesunate-amodiaquine (ASAQ)
Number of subjects: 720
Study 25626448 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL) vs Dihydroartemisinin piperaquine (DHAP)
Number of subjects: 720
Study 23099620 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticlopidine (250 mg twice daily)
Number of subjects: 12
Study 23099620 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticlopidine (250 mg twice daily) + Itraconazole (200 mg once daily)
Number of subjects: 12
Study 23099620 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 20157716 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiochemotherapy (RTCT)
Number of subjects: 3517
Study 20157716 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy (RT)
Number of subjects: 3517
Study 20225473 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etch adhesive (Clearfil SE Bond: SE)
Number of subjects: 0
Study 20225473 — intervention group
Group type: COMPARATOR
Intervention: Total-etch adhesive (Single Bond 2: SB)
Number of subjects: 0
Study 20225473 — intervention group
Group type: COMPARATOR
Intervention: Collagenase solution
Number of subjects: 0
Study 20225473 — intervention group
Group type: COMPARATOR
Intervention: Esterase solution
Number of subjects: 0
Study 20225473 — intervention group
Group type: COMPARATOR
Intervention: Phosphate buffer solution
Number of subjects: 0
Study 16825003 — intervention group
Group type: EXPERIMENTAL
Intervention: Discretionary use of contrast media
Number of subjects: 0
Study 16825003 — intervention group
Group type: COMPARATOR
Intervention: Standard echocardiography without contrast media
Number of subjects: 0
Study 12899644 — intervention group
Group type: EXPERIMENTAL
Intervention: Basiliximab 20mg intravenously on days 0 and 4
Number of subjects: 1185
Study 12899644 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1185
Study 10657767 — intervention group
Group type: EXPERIMENTAL
Intervention: Broad spectrum herbal therapy ointment (BSHT) at 1% v/v
Number of subjects: 50
Study 9088399 — intervention group
Group type: EXPERIMENTAL
Intervention: Bendazac lysine
Number of subjects: 12
Study 9088399 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 8478306 — intervention group
Group type: EXPERIMENTAL
Intervention: Dirithromycin (500 mg once daily for 5-7 days)
Number of subjects: 161
Study 8478306 — intervention group
Group type: COMPARATOR
Intervention: Miocamycin (600 mg twice daily for 5-7 days)
Number of subjects: 161
Study 3021498 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium, 4 mg four times daily
Number of subjects: 54
Study 31648928 — intervention group
Group type: EXPERIMENTAL
Intervention: Project UPLIFT
Number of subjects: 107
Study 31648928 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 107
Study 29996476 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium supplementation (400 mg of magnesium oxide daily)
Number of subjects: 59
Study 29996476 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 29996476 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium supplementation
Number of subjects: 59
Study 27613505 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline (0.5mg BID × 5 doses)
Number of subjects: 19
Study 27613505 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 24502384 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus (CNI-free regimen)
Number of subjects: 81
Study 24502384 — intervention group
Group type: EXPERIMENTAL
Intervention: Modification of Diet in Renal Disease (four-variable)
Number of subjects: 81
Study 24502384 — intervention group
Group type: EXPERIMENTAL
Intervention: Nankivell
Number of subjects: 81
Study 24502384 — intervention group
Group type: COMPARATOR
Intervention: CNI-based regimen
Number of subjects: 81
Study 24502384 — intervention group
Group type: COMPARATOR
Intervention: CNI-free patients
Number of subjects: 81
Study 24502384 — intervention group
Group type: COMPARATOR
Intervention: CNI patients
Number of subjects: 81
Study 22261780 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified thresholding
Number of subjects: 41
Study 22261780 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified fuzzy C-means
Number of subjects: 41
Study 22261780 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified normalized cut method
Number of subjects: 41
Study 22261780 — intervention group
Group type: EXPERIMENTAL
Intervention: Preprocessing and postprocessing
Number of subjects: 41
Study 22261780 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified methods using textural energy and Hounsfield value
Number of subjects: 41
Study 22261780 — intervention group
Group type: EXPERIMENTAL
Intervention: All methods
Number of subjects: 41
Study 20347363 — intervention group
Group type: EXPERIMENTAL
Intervention: Damping factor measurement in patients with vertebral fractures
Number of subjects: 67
Study 20347363 — intervention group
Group type: COMPARATOR
Intervention: Damping factor measurement in patients without vertebral fractures
Number of subjects: 67
Study 17547877 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine artery embolization (UAE)
Number of subjects: 177
Study 17547877 — intervention group
Group type: COMPARATOR
Intervention: Hysterectomy
Number of subjects: 177
Study 16075984 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG polysaccharides nucleic acid plus ketotefen
Number of subjects: 60
Study 16075984 — intervention group
Group type: COMPARATOR
Intervention: Ketotefen
Number of subjects: 60
Study 12270988 — intervention group
Group type: EXPERIMENTAL
Intervention: Mupirocin (thrice-weekly application)
Number of subjects: 50
Study 12270988 — intervention group
Group type: COMPARATOR
Intervention: Control (no ointment)
Number of subjects: 50
Study 9883435 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CyA)
Number of subjects: 31
Study 9883435 — intervention group
Group type: EXPERIMENTAL
Intervention: Etretinate
Number of subjects: 31
Study 8564652 — intervention group
Group type: EXPERIMENTAL
Intervention: Propacetamol on demand (D Group)
Number of subjects: 119
Study 8564652 — intervention group
Group type: COMPARATOR
Intervention: Propacetamol systematically (S Group)
Number of subjects: 119
Study 8564652 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (D Group and S Group)
Number of subjects: 119
Study 2195734 — intervention group
Group type: EXPERIMENTAL
Intervention: cyclosporin (Cs) treatment for one year
Number of subjects: 188
Study 2195734 — intervention group
Group type: EXPERIMENTAL
Intervention: cyclosporin (Cs) treatment for three months
Number of subjects: 188
Study 2195734 — intervention group
Group type: EXPERIMENTAL
Intervention: cyclosporin (Cs) treatment for twelve months
Number of subjects: 188